221 related articles for article (PubMed ID: 21502434)
1. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
[TBL] [Abstract][Full Text] [Related]
2. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.
Logginidou H; Ao X; Russo I; Henske EP
Chest; 2000 Jan; 117(1):25-30. PubMed ID: 10631194
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
De Rosa N
Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
[TBL] [Abstract][Full Text] [Related]
5. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.
Gao L; Yue MM; Davis J; Hyjek E; Schuger L
Virchows Arch; 2014 Apr; 464(4):495-503. PubMed ID: 24570392
[TBL] [Abstract][Full Text] [Related]
6. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
[TBL] [Abstract][Full Text] [Related]
7. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.
Schoolmeester JK; Park KJ
Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558
[TBL] [Abstract][Full Text] [Related]
8. Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis.
Yoshida S; Hayashi T; Ishii N; Yoshinaga A; Ohno R; Terao T; Watanabe T; Yamada T; Osada H
Int Urol Nephrol; 2006; 38(3-4):413-5. PubMed ID: 17111084
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
10. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
Johnson J; Somerfield W; Johnson SR
Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
[TBL] [Abstract][Full Text] [Related]
11. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis].
Urban T
Rev Mal Respir; 2007 Jun; 24(6):725-40. PubMed ID: 17632432
[TBL] [Abstract][Full Text] [Related]
14. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary lymphangioleiomyomatosis (LAM). Diagnostic usefulness of immunohistochemical markers].
Serrano Pardo R; Sotelo Rodríguez MT; Alvarez Martínez C; Ballestin Carcavilla C; Larrú Cabrero E
Arch Bronconeumol; 1998 Nov; 34(10):509-11. PubMed ID: 9881218
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
17. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis.
Bisceglia M; D'Alessandro V; Simeone A; Ben-Dor D; Pasquinelli G
Adv Anat Pathol; 2010 Nov; 17(6):445-52. PubMed ID: 20966650
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary lymphangioleiomyomatosis with concomitant tuberous sclerosis complex diagnosed by video-assisted thoracoscopic surgery.
Taniguchi Y; Haruki T; Fujioka S; Adachi Y; Miwa K; Nakamura H
Gen Thorac Cardiovasc Surg; 2008 Feb; 56(2):81-4. PubMed ID: 18297464
[TBL] [Abstract][Full Text] [Related]
20. Lymphangioleiomyomatosis.
Johnson SR; Taveira-DaSilva AM; Moss J
Clin Chest Med; 2016 Sep; 37(3):389-403. PubMed ID: 27514586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
